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a,b EgyptObjective: As a consequence of leftward shift of the interventricular septum and of pericardial restraint, related to
the degree of right ventricular dilation, alveolar hypoxia and related pulmonary vascular changes, left ventricular
function is influenced by chronic obstructive pulmonary disease (COPD). The aim of this study was to assess the
prevalence of echocardiographic abnormalities by conventional echocardiography and Doppler tissue imaging (DTI) in
COPD patients according to the degree of disease severity.
Methods: We enrolled forty consecutive patients with COPD and twenty matched control. Twenty of the patients
were suffering from mild form of COPD, twenty were suffering from severe form of COPD as decided by
pulmonary function test and arterial blood gases and twenty apparently healthy non COPD control persons were
subjected to echocardiographic assessment to left ventricular diastolic and systolic functions by conventional
echocardiography and DTI at the mitral annulus.
Results: There were no significant statistical difference between the three groups as regards the age and the
gender. There were significant statistical differences between the patients and the control as regards the diastolic
functions of the left ventricle. E and A waves obtained by conventional Doppler and by DTI showed significant
statistical difference between mild, severe forms of COPD and control subjects. The degree of diastolic dysfunction
increased significantly with increase of the severity of COPD.
Conclusion: Left ventricular diastolic function is significantly affected in patients with COPD and the degree of
affection is related to the severity of COPD.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
COPD chronic obstructive pulmonary disease
DTI Doppler tissue imaging
LV left ventricle
RV right ventricle
GOLD Global Initiative for Chronic Obstructive Lung
Disease
FEV1 Forced expiratory volume
FVC flow-volume curves
IC inspiratory capacity
TLC total lung capacity
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Chronic obstructive pulmonary disease(COPD) is a common cause of pulmonary
arterial hypertension. Increased right ventricular
afterload caused by pulmonary hypertension in
patients with COPD eventually leads to dilation
of the right ventricle (RV), with or without hyper-
trophy. There are several studies demonstrating
that patients with COPD have RV systolic and/or
diastolic dysfunction [1,2]. Previous studies have
shown that patients with COPD also have left
ventricular (LV) diastolic dysfunction [3,4].
Impairment of LV diastolic filling is related to
the prolongation of LV isovolumic relaxation and
the impediment of rapid filling, as a result of left-
ward interventricular septal shift and distortion of
early diastolic geometry [5,6]. Mechanisms of
impaired LV filling in very severe COPD include
alveolar hypoxia, related pulmonary vascular
changes, and pulmonary hyperinflation. Alveolar
hypoxia causes pulmonary artery vasoconstriction
and vascular remodeling [7]. Inflammation is con-
sidered one of the systemic manifestations of
COPD and provides an alternative hypothesis
for the explanation of the relationship between
airflow limitation and cardiovascular risk [8].
Doppler tissue imaging (DTI) is evolving as a
useful echocardiographic tool for quantitative
assessment of left ventricular (LV) systolic and
diastolic function. Studies have explored the prog-
nostic role of DTI-derived parameters in major
cardiac diseases, such as heart failure, acute
myocardial infarction, and hypertension. In these
conditions, myocardial mitral annular or basal
segment systolic and early diastolic velocities have
been shown to predict mortality or cardiovascular
events [9].
The aim of this study is to assess the prevalence
of echocardiographic abnormalities by conven-
tional echocardiography and Doppler tissue imag-
ing in COPD patients according to the degree of
disease severity.Methods
Patient selection
The study included 40 consecutive patients from
outpatient clinics, while the control group com-
prised 20 age and sex-matched, healthy subjects
who were not COPD patients. COPD diagnosis
was confirmed according to the guidelines estab-
lished in the Global Initiative for ChronicObstructive Lung Disease (GOLD). COPD was
categorized according to the GOLD stages, consid-
ering the Forced expiratory volume (FEV1) (% pre-
dicted) and arterial blood gas values [10,11].
Before inclusion, an informed written consent
was obtained from each patient after full explana-
tion of the study protocol. The protocol was
reviewed and approved by our local institutional
human research committee, which conforms to
the ethical guidelines of the 1975 Declaration of
Helsinki, revised in 2002.
The exclusion criteria consisted of a primary
diagnosis of other respiratory diseases such as
asthma, restrictive disorders, tuberculosis seque-
lae, or interstitial fibrosis, as well as sleep
apnea/hypopnea syndrome, or lung cancer. In
addition, a primary diagnosis of unstable angina,
congestive heart failure (New York Heart
Association class III or IV) or other chronic
diseases, such as uncontrolled diabetes mellitus,
kidney or liver failure and cancer, also constituted
grounds for exclusion. Patients were assessed on
three different days of the same week through
clinical evaluations, spirometry, and echocardio-
gram tests.Pulmonary function tests
Pulmonary function tests (PFT) were carried out
in the pulmonary function unit using the flow-
volume curves (FVC). Subjects performed the
FVC maneuver by inhaling fully and then
exhaling as rapidly as possible; to complete the
loop, subjects inhaled as rapidly as possible from
the maximal expiratory level back to maximal
inhalation. An arterial sample was obtained from
the radial artery to perform arterial blood gases
(ABGs) for measuring the arterial oxygen tension
(PO2).
COPD patients were divided into two groups,
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mal pulmonary function tests.
The first group included mild cases of COPD,
characterized by FEV1/FVC < 70%, FEV1P 50%
of predicted, with or without chronic symptoms.
The second group included severe and very
severe cases of COPD, characterized by
FEVl/FVC < 70%, FEV1 < 50% of predicted, with
or without chronic symptoms. Control subjects
had normal PFT showing FEV1/FVC > 70%,
FEV1 > 80% of predicted.Echocardiography
Echocardiography was performed on all sub-
jects according to the same protocol with use of
GE Medical System Vivid 7 ultrasound machine
equipped with 2–4 MHz sector transducer probe.
With participants positioned in left lateral decubi-
tus and monitored using an electrocardiographic
lead, the following echocardiographic cuts were
performed: short parasternal axis to measure ven-
tricles, left atrium and apical two, four and five
chambers to evaluate cavities and systolic and
diastolic functions of ventricles. All measure-
ments were performed in accordance with the
guidelines/recommendations of American Society
of Echocardiography/European Association of
Echocardiography [12]. The echocardiographic
analysis was performed blinded to COPD
severity.
Parameters obtained through parasternal
approaches in the M-mode projection were
analyzed: left ventricular end diastolic diameter
(EDD), left ventricular end systolic diameter
(ESD), interventricular septum (IVS), left ventricu-
lar posterior wall thickness (PW), right ventricular
end diastolic diameter (RVEDD), right ventricular
end systolic diameter (RVESD), and left atrial
diameter (LA).
The assessment of the left ventricular systolic
function consisted of left ventricular ejection frac-
tion (EF%) obtained according to Simpson’s
formula.
To assess left ventricular diastolic function, iso-
volumetric relaxation time (IVRT), which is the
interval from the aortic valve closure signal to
the mitral valve opening signal, and the following
transmitral inflow parameters were measured
(pulsed wave Doppler registration with gate
placed at the tip of open mitral valve leaflets):
peak velocity of the early E-wave transmitral flow
(E), peak velocity of late A-wave transmitral flow
(A), and the ratio (E/A) was derived. Pressure half
time (PHT), which is the half time of the decelera-
tion of the early diastolic transmitral flow andwhich reflects the rapidity of the pressure gradi-
ent drop from LA to LV, was obtained.
Tricuspid regurgitant (TR) flow was identified in
continuous Doppler mode from the apical four
chamber view. The Bernoulli equation was used
to calculate the systolic tricuspid gradient that
equals 4 V2. Right atrial was arbitrarily fixed to a
value of 100 mmHg and right ventricular systolic
pressure (RVSP) was obtained as = gradient
RV/RA + 10. Pulmonary acceleration time (PAT)
was defined as the time from the onset of pul-
monary flow to the maximum pulmonary velocity.
Mitral annular velocity by DTI
We used the same GE Vivid Seven machine
using a commercially available imaging system
equipped with a 2–4 MHz transducer and sec-
ondary harmonic imaging to optimize endocardial
border visualization. From the apical four and two
chamber views, the longitudinal mitral annular
velocities were recorded from septal, lateral, infe-
rior and anterior LV sites using PW-DTI. A mean
value from the above four sites was used to assess
global systolic and diastolic function. Three major
velocities were taken into account: the positive
peak systolic velocity when the mitral ring moved
towards the cardiac apex due to longitudinal
contraction of the LV, and two negative diastolic
velocities when the mitral annulus moved towards
the base away from the apex; one during the early
phase of diastole, and the other in the late phase of
diastole. A mean of three consecutive cycles was
used to calculate all echo-Doppler parameters.
Statistical analysis
Data are presented as mean ± SD. The
Chi-squared test was used to compare differences
between proportions. The Analysis of variance
(ANOVA) test was used for analysis of continuous
data. The Bonferroni test was performed for com-
parison between each two of the three variables
with p value < 0.05 as per ANOVA test. A proba-
bility value of p < 0.05 was considered statistically
significant. Analyses were performed with SPSS
version 12.0 statistical package (SPSS Inc.,
Chicago, IL, USA). Differences were considered
significant if the null hypothesis could be rejected
at the .05 probability level.Results
There was no significant statistical difference
between the three groups as regards age and
sex. The mean age was 52.75 ± 5.11 years for
patients with mild COPD, 50.30 ± 4.40 for patients
Table 1. Baseline characteristics in patients with COPD and control subjects.
Control Mild Severe
Age 51.40 ± 3.89 52.75 ± 5.11 50.30 ± 4.40
Male 10 (50%) 10 (50%) 9 (45%)
Heart rateO 71.80 ± 4.41 82.35 ± 4.05 84.85 ± 3.77
Diabetes mellitus 0 (0%) 1 (5%) 2 (10%)
Dyslipidemia 2 (10%) 3 (15%) 3 (15%)
Systolic blood pressure 116.01 ± 15.12 114.10 ± 19.32 120.21 ± 16.21
Diastolic blood pressure 72.65 ± 8.20 74.67 ± 11.21 74.56 ± 10.32
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group with p > 0.05. As regards the gender we
had ten male patients with mild COPD, nine male
patients with severe COPD and ten males as con-
trol subjects with p > 0.05.
Heart rate was 82.35 ± 4.05 bpm in patients with
mild COPD, 84.85 ± 3.77 bpm in patients with sev-
ere COPD and 71.80 ± 4.41 bpm in control group
with p < 0.001 (Table 1).Table 2. Echocardiographic parameters in patients with COPD and
Control Mi
EDD (mm) 47.10 ± 3.28 47.
ESD (mm) 29.70 ± 3.68 30.
IVS (mm) 8.50 ± 1.08 9.
PW (mm) 8.50 ± 1.26 9.
RVEDD(mm)*,# 20.00 ± 3.19 35.
RVESD (mm)*,# 15.40 ± 2.79 25.
EF (%) 66.30 ± 5.79 63.
LA (mm) 34.50 ± 2.22 35.
RVSP*,#,@ 24.40 ± 3.06 44.
PAT (msec)*,#,@ 130.00 ± 14.90 81.
Variables are expressed as mean ± standard deviation.
EDD = Left ventricular end diastolic dimension, ESD = Left ventricular
PW = Posterior wall thickness, RVEDD = Right ventricular end diastolic dime
fraction, LA = Left atrium, RVSP = Right ventricular systolic pressure, PAT =
* Significant p value between control group and mild group.
# Significant p value between control group and severe group.
@ Significant p value between mild group and severe group.
Table 3. Doppler parameters: Left ventricular filling in patients wi
Control Mild
MVE (cm/sec)*,# 79.90 ± 9.80 62.8
MVA (cm/sec)#,@ 61.10 ± 9.31 68.1
MVE/A*,#,@ 1.32 ± 0.18 0.8
IVRT (msec)*,# 81.60 ± 7.53 101.5
PHT (msec) 75.50 ± 9.84 77.7
Variables are expressed as mean ± standard deviation.
MVE = Mitral valve E wave, MVA = Mitral valve A wave, MVE/A = Mitral va
time.
* Significant p value between control group and mild group.
# Significant p value between control group and severe group.
@ Significant p value between mild group and severe group.As regards LV dimensions systolic function and
left atrial diameter there were no significant statis-
tical difference between the three groups. The
condition was totally different regarding the dias-
tolic function of LV and all the echocardiographic
and Doppler function of the right side e.g.
RVEDD, RVESD, TR, RVSP and PAT (Table 2).
The LV diastolic function parameters in the
studied groups are shown in Table 3, the mitralcontrol subjects.
ld Severe p value
21 ± 3.80 48.20 ± 4.58 0.678
95 ± 3.72 31.20 ± 4.00 0.588
20 ± 1.19 9.45 ± 1.14 0.114
25 ± 1.06 9.25 ± 1.11 0.183
05 ± 5.01 37.80 ± 6.46 <0.001
05 ± 4.71 26.35 ± 4.93 <0.001
05 ± 5.77 64.35 ± 5.85 0.357
30 ± 3.41 36.65 ± 3.32 0.184
35 ± 8.20 57.25 ± 10.44 <0.001
00 ± 7.88 62.00 ± 15.76 <0.001
end systolic dimension, IVS = Interventricular septum thickness,
nsion, RVESD = Right ventricular end systolic dimension, EF = Ejection
Pulmonary acceleration time.
th COPD and control subjects.
Severe p value
5 ± 13.16 64.85 ± 14.26 0.004
0 ± 13.30 79.75 ± 11.58 <0.001
9 ± 0.09 0.76 ± 0.09 <0.001
0 ± 7.79 105.60 ± 7.13 <0.001
5 ± 10.81 68.20 ± 14.99 0.056
lve E/A ratio, IVRT = isovolumetric relaxation time, PHT = Pressure half
Table 4. Mitral annular pulsed wave tissue Doppler in patients with COPD and control subjects.
Control Mild Severe p value
LAT S0 (cm/sec) 14.27 ± 0.97 13.62 ± 1.66 13.68 ± 0.73 0.370
LAT E0 (cm/sec)*,#,@ 12.24 ± 1.70 7.74 ± 0.49 6.37 ± 0.56 <0.001
LAT A0 (cm/sec)*,#,@ 6.81 ± 0.52 11.01 ± 0.63 14.19 ± 1.65 <0.001
SEP S0 (cm/sec) 7.86 ± 0.67 7.94 ± 0.64 7.80 ± 0.54 0.786
SEP E0 (cm/sec)*,#,@ 12.19 ± 1.23 7.60 ± 0.33 6.37 ± 0.56 <0.001
SEP A0 (cm/sec)*,#,@ 6.91 ± 0.65 11.59 ± 0.68 14.22 ± 1.85 <0.001
ANT S0 (cm/sec) 12.48 ± 0.38 11.91 ± 0.61 11.99 ± 0.57 0.033
ANT E0 (cm/sec)*,#,@ 12.24 ± 1.70 7.90 ± 0.53 6.33 ± 0.54 <0.001
ANT A0 (cm/sec)*,#,@ 6.96 ± 0.90 11.72 ± 0.66 14.60 ± 1.16 <0.001
INF S0 (cm/sec) 9.91 ± 0.62 10.26 ± 0.98 10.02 ± 0.55 0.439
INF E0 (cm/sec)*,#,@ 14.14 ± 0.76 7.69 ± 0.49 5.88 ± 0.52 <0.001
INF A0 (cm/sec)*,#,@ 7.82 ± 0.37 11.05 ± 1.12 15.30 ± 2.49 <0.001
TOTAL S0 (cm/sec) 11.13 ± 0.27 10.90 ± 0.53 10.91 ± 0.38 0.349
TOTAL E0 (cm/sec)*,#,@ 12.70 ± 0.98 7.73 ± 0.20 6.24 ± 0.37 <0.001
TOTAL A0 (cm/sec)*,#,@ 7.12 ± 0.39 11.34 ± 0.57 14.58 ± 1.14 <0.001
TOTAL E0/A0 (cm/sec)*,#,@ 1.78 ± 0.12 0.68 ± 0.02 0.43 ± 0.04 <0.001
Variables are expressed as mean ± standard deviation.
LAT = Lateral mitral annular velocities, SEP = Septal mitral annular velocities, ANT = anterior mitral annular velocities, INF = inferior mitral annular
velocities. S0 = Positive peak systolic velocity, E0 = Negative early diastolic velocity, A0 = negative late diastolic velocity.
* Significant p value between control group and mild group.
# Significant p value between control group and severe group.
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significantly in patients with COPD compared
with the control subjects. E/A ratio was signifi-
cantly lower in patients with COPD p < 0.001.
Multiple comparisons were done to evaluate the
significant statistical difference between the three
groups to determine the relation between each
two groups individually.
The single values and the mean values obtained
by pulsed wave tissue Doppler imaging obtained
at the four sites of the mitral annulus revealed that
there was no significant statistical difference
between the COPD patients and the control group
as regards the systolic function of the LV.
Regarding the diastolic functions of the LV, there
were highly significant statistical difference
between the COPD patients and the control
group. When the diastolic functions of the LV
were studied in details, there were highly signifi-
cant statistical difference between the three
groups individually as shown in Table 4.Discussion
Echocardiography is the most common and fea-
sible non-invasive method to assess LV diastolic
function. In our study, E/A ratio was significantly
lower and IVRT was significantly longer in
patients with COPD. With DTI, there were signif-
icant statistical differences between control sub-
jects and COPD patients in E0, A0 and E0/A0 ratio
of the mitral annular velocities.
The E/A ratio mainly represents a measurement
of LV filling. According to previous studiesperformed in COPD patients, a lower E/A ratio
means an increased atrial contribution to this fill-
ing. This occurs in both the presence and absence
of elevated pulmonary artery pressure. However,
LV diastolic dysfunction in COPD could be the
result of decreased preload or pathological
myocardial compliance. It is unknown which
echocardiographic parameters are best to mea-
sure LV diastolic dysfunction [13]. In a
population-based study of subjects without very
severe COPD, Barr et al [14] found that percent
emphysema and the severity of airflow obstruc-
tion were associated with significant decrements
in left ventricular filling and cardiac output.
They speculated that the subclinical loss of the
pulmonary capillary bed in patients with mild
emphysema was responsible for the left ventricu-
lar hypofilling, whereas hyperinflation of the lung
only had a role in very severe COPD [14]. Waltz
et al [15] found hyperinflation of the lung to have
a stronger association with the left ventricular
end-diastolic diameter than airflow obstruction
or the diffusion capacity for carbon monoxide in
138 patients with COPD ranging from mild to
severe. Therefore, it was assumed that hyperinfla-
tion had an effect on decreasing pulmonary
vascular compliance that was mediated by an ele-
vated intrinsic positive end-expiratory pressure
[16], and that, in turn, led to an increased right
ventricular load, a reduced right ventricular stroke
volume, and left ventricular hypofilling. In line
with this assumption, it was found that right
ventricular ejection time as a surrogate for right
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ology of left ventricular hypofilling is not fully
understood, the condition was clinically relevant
for patients with COPD, since it independently
affected their physical activity and exercise toler-
ance [18]. Reversible ischemic defects are quite
common (50%) in advanced COPD patients with
LV diastolic dysfunction, without the presence of
common risk factors. This association needs fur-
ther evaluation [19].
Unlike our study and previous reports, Schoos
et al [20] did not find decreasing E/A and increas-
ing deceleration time of E with increasing hyper-
inflation [15] or COPD severity [21], nor did they
find decreasing E/A with increasing SPAP [22].
In their overall population, E/A and DT were
numerically very similar compared to normal
individuals [23]. However, diastolic mitral
Doppler data in COPD could be interpreted as a
sign of low LV preload and not necessarily an
intrinsic impairment in LV relaxation/compliance.
Decreasing E/E0 with increasing COPD severity
indicates lower left ventricular filling pressures
[23], which lends support to the concept of
reduced preload in COPD. In the study by
Schoos et al [20], the design was cross-sectional,
making firm conclusions about causality impossi-
ble. Further, Schoos et al did not have a control
group, and therefore required the use of reference
values from the literature.
Several factors can be put forward to explain
changes in LV filling profile, some of which are
well evidenced by Doppler echocardiography.
The first and the most important is the signifi-
cantly increased HR in the COPD group.
Tachycardia shortened the diastolic filling period,
and atrial contraction may have occurred before
the early filling was completed. The transmitral
A peak velocity will be higher than it would be if
HR were slower. This tachycardia may be due to
multiple causes, including hypoxemia or medica-
tions [24]. All our patients presented with marked
hypoxemia, and COPD patients are known to
show a more pronounced reaction to low blood
oxygen content. Medications given to the COPD
patients included beta2-agonist, theophylline or
atropine, all potentially responsible for tachycar-
dia. This decreased LV preload in stable patients
with COPD has rarely been reported in the litera-
ture, and may have contributed to the acceleration
of the HR. Reduced LV preload could be due to
reduced venous return flow or to hypovolemia.
Obstruction of the bronchi, severe in our COPD
patients, may have increased intrinsic positiveend-expiratory pressure and limited the venous
return blood flow [25].
Studies have evaluated patients who were hos-
pitalized for exacerbation of COPD associated
with diastolic dysfunction, and have shown that
left diastolic dysfunction increased the risk of hos-
pitalization for exacerbation [26]. These data rein-
force the importance of left ventricular diastolic
evaluation in COPD patients.
Mitral annular or basal LV velocities reflect the
long-axis motion of the ventricle, which is an
important component of LV systolic and diastolic
function. Subendocardial fibers make a substan-
tial contribution to long-axis function, and these
are particularly susceptible to disturbance by var-
ious diseases and pathologies [9].
The evaluation of LV diastolic function in
patients with COPD has primarily focused on
examination of conventional mitral inflow velocity
using Doppler echocardiography. However, inter-
pretation of the patterns derived from transmitral
Doppler flow is often limited by the influence of
hemodynamic factors such as heart rate, afterload,
preload, and intravascular volume [27].
Mitral annulus motion is less load dependent
than conventional mitral inflow variables, and its
assessment by DTI appears to be useful for evalu-
ating diastolic function, especially in detecting a
pseudonormalization pattern of mitral inflow.
Mitral annulus velocities primarily reflect longitu-
dinal motion due to longitudinally directed fibers,
but also reflect global LV function. It was reported
that E velocity of DTI of 8 cm/sec was used as a
cut-off value in determining LV diastolic dysfunc-
tion. The DTI method is therefore a valuable tool
for assessing global LV diastolic function in patho-
logical conditions. In patients with idiopathic pul-
monary hypertension as proved with invasive
measurements, DTI of lateral mitral annulus was
able to predict the presence of normal or reduced
mean pulmonary capillary wedge pressure [28].
The limitations of this study are the small sam-
ple size. In addition, strain and strain rate were
not performed. Body plethysmography was not
performed, and the diffusion capacity or the ratio
of inspiratory capacity (IC) to total lung capacity
(TLC) as well as residual volume are unknown.
These parameters allow judgement on the degree
of lung hyperinflation, which is known to influ-
ence heart function – both systolic and diastolic.
Further studies are needed to detect additional
abnormalities and throw light on how to deal with
them in order to improve morbidity and mortality
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difference between COPD patients, control sub-
jects, and patients with mild and severe COPD
using PFTs for left ventricular diastolic function
determined by both conventional Doppler and
DTI. We demonstrated that the degree of LV dias-
tolic dysfunction is related to the degree of COPD
severity, as shown in Table 4.
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